JPWO2021113744A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021113744A5 JPWO2021113744A5 JP2022533373A JP2022533373A JPWO2021113744A5 JP WO2021113744 A5 JPWO2021113744 A5 JP WO2021113744A5 JP 2022533373 A JP2022533373 A JP 2022533373A JP 2022533373 A JP2022533373 A JP 2022533373A JP WO2021113744 A5 JPWO2021113744 A5 JP WO2021113744A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- derived
- receptor
- immune cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002865 immune cell Anatomy 0.000 claims 54
- 210000004027 cell Anatomy 0.000 claims 37
- 238000011282 treatment Methods 0.000 claims 23
- 102000005962 receptors Human genes 0.000 claims 22
- 108020003175 receptors Proteins 0.000 claims 22
- 150000001875 compounds Chemical class 0.000 claims 21
- 206010028980 Neoplasm Diseases 0.000 claims 20
- 238000000034 method Methods 0.000 claims 19
- 102000003812 Interleukin-15 Human genes 0.000 claims 17
- 108090000172 Interleukin-15 Proteins 0.000 claims 17
- 239000000427 antigen Substances 0.000 claims 17
- 102000036639 antigens Human genes 0.000 claims 17
- 108091007433 antigens Proteins 0.000 claims 17
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 15
- 102000004127 Cytokines Human genes 0.000 claims 14
- 108090000695 Cytokines Proteins 0.000 claims 14
- 238000005138 cryopreservation Methods 0.000 claims 14
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 14
- 229960003957 dexamethasone Drugs 0.000 claims 14
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 14
- 210000000822 natural killer cell Anatomy 0.000 claims 13
- 210000000130 stem cell Anatomy 0.000 claims 13
- -1 41BBL Proteins 0.000 claims 12
- 210000001744 T-lymphocyte Anatomy 0.000 claims 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 239000012636 effector Substances 0.000 claims 10
- 108020001507 fusion proteins Proteins 0.000 claims 10
- 102000037865 fusion proteins Human genes 0.000 claims 10
- 230000014509 gene expression Effects 0.000 claims 10
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 9
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 9
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 claims 8
- 108010024164 HLA-G Antigens Proteins 0.000 claims 8
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims 8
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims 8
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 8
- 230000036961 partial effect Effects 0.000 claims 8
- 101100382122 Homo sapiens CIITA gene Proteins 0.000 claims 7
- 102000000704 Interleukin-7 Human genes 0.000 claims 7
- 108010002586 Interleukin-7 Proteins 0.000 claims 7
- 102100026371 MHC class II transactivator Human genes 0.000 claims 7
- 108700002010 MHC class II transactivator Proteins 0.000 claims 7
- 210000003719 b-lymphocyte Anatomy 0.000 claims 7
- 238000010257 thawing Methods 0.000 claims 7
- RJBDSRWGVYNDHL-XNJNKMBASA-N (2S,4R,5S,6S)-2-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-amino-6-[(1S,2R)-2-[(2S,4R,5S,6S)-5-amino-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-4-hydroxyoxane-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@@H](O)\C=C\CCCCCCCCCCCCC RJBDSRWGVYNDHL-XNJNKMBASA-N 0.000 claims 6
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims 6
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 6
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 6
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 6
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims 6
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 6
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims 6
- 102000003735 Mesothelin Human genes 0.000 claims 6
- 108090000015 Mesothelin Proteins 0.000 claims 6
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 6
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 6
- 230000007812 deficiency Effects 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims 6
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 5
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 5
- 102100032912 CD44 antigen Human genes 0.000 claims 5
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 5
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 5
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 5
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims 5
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims 5
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims 5
- 102000000588 Interleukin-2 Human genes 0.000 claims 5
- 108010002350 Interleukin-2 Proteins 0.000 claims 5
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims 5
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims 5
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims 5
- 230000003013 cytotoxicity Effects 0.000 claims 5
- 231100000135 cytotoxicity Toxicity 0.000 claims 5
- 229960004942 lenalidomide Drugs 0.000 claims 5
- GOTYRUGSSMKFNF-UHFFFAOYSA-N lenalidomide Chemical compound C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 claims 5
- 239000010445 mica Substances 0.000 claims 5
- 229910052618 mica group Inorganic materials 0.000 claims 5
- MDEJTPWQNNMAQF-BVMLLJBZSA-N (1s,3s,4r)-4-[(3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methylidene-3,3a,4,5,6,7-hexahydro-2h-inden-5-yl]-3-(hydroxymethyl)-4-methylcyclohexan-1-ol Chemical compound C[C@]1([C@H]2CC[C@]3([C@H]([C@@H]2CN)CCC3=C)C)CC[C@H](O)C[C@@H]1CO MDEJTPWQNNMAQF-BVMLLJBZSA-N 0.000 claims 4
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 4
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 4
- 102100027314 Beta-2-microglobulin Human genes 0.000 claims 4
- 108700012439 CA9 Proteins 0.000 claims 4
- 102100024423 Carbonic anhydrase 9 Human genes 0.000 claims 4
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 4
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 4
- 108010009685 Cholinergic Receptors Proteins 0.000 claims 4
- 102100039061 Cytokine receptor common subunit beta Human genes 0.000 claims 4
- 241000701022 Cytomegalovirus Species 0.000 claims 4
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 4
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 4
- 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 claims 4
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 4
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 4
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 claims 4
- 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 claims 4
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims 4
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims 4
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 claims 4
- 101001005728 Homo sapiens Melanoma-associated antigen 1 Proteins 0.000 claims 4
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 4
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims 4
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims 4
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims 4
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims 4
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 4
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims 4
- 101150069255 KLRC1 gene Proteins 0.000 claims 4
- 102000017578 LAG3 Human genes 0.000 claims 4
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 claims 4
- 101100404845 Macaca mulatta NKG2A gene Proteins 0.000 claims 4
- 102100025050 Melanoma-associated antigen 1 Human genes 0.000 claims 4
- 102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 claims 4
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims 4
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims 4
- 102000036673 PRAME Human genes 0.000 claims 4
- 108060006580 PRAME Proteins 0.000 claims 4
- 101710120463 Prostate stem cell antigen Proteins 0.000 claims 4
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 4
- 101001039269 Rattus norvegicus Glycine N-methyltransferase Proteins 0.000 claims 4
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 4
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims 4
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims 4
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 4
- 102100022748 Wilms tumor protein Human genes 0.000 claims 4
- 101710127857 Wilms tumor protein Proteins 0.000 claims 4
- 102000034337 acetylcholine receptors Human genes 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 4
- 230000011664 signaling Effects 0.000 claims 4
- 102100026882 Alpha-synuclein Human genes 0.000 claims 3
- 102100030346 Antigen peptide transporter 1 Human genes 0.000 claims 3
- 102100030343 Antigen peptide transporter 2 Human genes 0.000 claims 3
- 102100020986 DNA-binding protein RFX5 Human genes 0.000 claims 3
- 102100021044 DNA-binding protein RFXANK Human genes 0.000 claims 3
- 102100025137 Early activation antigen CD69 Human genes 0.000 claims 3
- 108010087819 Fc receptors Proteins 0.000 claims 3
- 102000009109 Fc receptors Human genes 0.000 claims 3
- 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 3
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims 3
- 101000937544 Homo sapiens Beta-2-microglobulin Proteins 0.000 claims 3
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 3
- 101001075432 Homo sapiens DNA-binding protein RFX5 Proteins 0.000 claims 3
- 101001075464 Homo sapiens DNA-binding protein RFXANK Proteins 0.000 claims 3
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 claims 3
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims 3
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims 3
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 3
- 101001023712 Homo sapiens Nectin-3 Proteins 0.000 claims 3
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 3
- 101000979565 Homo sapiens Protein NLRC5 Proteins 0.000 claims 3
- 101001075466 Homo sapiens Regulatory factor X-associated protein Proteins 0.000 claims 3
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims 3
- 101000687808 Homo sapiens Suppressor of cytokine signaling 2 Proteins 0.000 claims 3
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims 3
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 3
- 108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 3
- 102100035487 Nectin-3 Human genes 0.000 claims 3
- 102100023432 Protein NLRC5 Human genes 0.000 claims 3
- 102100021043 Regulatory factor X-associated protein Human genes 0.000 claims 3
- 102100024784 Suppressor of cytokine signaling 2 Human genes 0.000 claims 3
- 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 3
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims 3
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 3
- 101800000849 Tachykinin-associated peptide 2 Proteins 0.000 claims 3
- 102100028082 Tapasin Human genes 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 230000003394 haemopoietic effect Effects 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000002609 medium Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 210000000581 natural killer T-cell Anatomy 0.000 claims 3
- 230000019491 signal transduction Effects 0.000 claims 3
- 108010059434 tapasin Proteins 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 2
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 2
- 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 claims 2
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 2
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 2
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims 2
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims 2
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 2
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims 2
- 108010008629 CA-125 Antigen Proteins 0.000 claims 2
- 102100024217 CAMPATH-1 antigen Human genes 0.000 claims 2
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 2
- 108010065524 CD52 Antigen Proteins 0.000 claims 2
- 102100025221 CD70 antigen Human genes 0.000 claims 2
- 102000024905 CD99 Human genes 0.000 claims 2
- 108060001253 CD99 Proteins 0.000 claims 2
- 102000001301 EGF receptor Human genes 0.000 claims 2
- 102000003886 Glycoproteins Human genes 0.000 claims 2
- 108090000288 Glycoproteins Proteins 0.000 claims 2
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims 2
- 101000718211 Homo sapiens Adhesion G protein-coupled receptor E2 Proteins 0.000 claims 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 2
- 101000912622 Homo sapiens C-type lectin domain family 12 member A Proteins 0.000 claims 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims 2
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 claims 2
- 101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 claims 2
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims 2
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims 2
- 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 claims 2
- 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 claims 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 2
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims 2
- 101000662902 Homo sapiens T cell receptor beta constant 2 Proteins 0.000 claims 2
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims 2
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims 2
- 102000026633 IL6 Human genes 0.000 claims 2
- 102100032816 Integrin alpha-6 Human genes 0.000 claims 2
- 102100025306 Integrin alpha-IIb Human genes 0.000 claims 2
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims 2
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims 2
- 102000003814 Interleukin-10 Human genes 0.000 claims 2
- 108090000174 Interleukin-10 Proteins 0.000 claims 2
- 102000003815 Interleukin-11 Human genes 0.000 claims 2
- 108090000177 Interleukin-11 Proteins 0.000 claims 2
- 108010065805 Interleukin-12 Proteins 0.000 claims 2
- 102000013462 Interleukin-12 Human genes 0.000 claims 2
- 102000003810 Interleukin-18 Human genes 0.000 claims 2
- 108090000171 Interleukin-18 Proteins 0.000 claims 2
- 102100030704 Interleukin-21 Human genes 0.000 claims 2
- 102000004388 Interleukin-4 Human genes 0.000 claims 2
- 108090000978 Interleukin-4 Proteins 0.000 claims 2
- 108090001005 Interleukin-6 Proteins 0.000 claims 2
- 102000000585 Interleukin-9 Human genes 0.000 claims 2
- 108010002335 Interleukin-9 Proteins 0.000 claims 2
- 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 claims 2
- 108010008707 Mucin-1 Proteins 0.000 claims 2
- 102000007298 Mucin-1 Human genes 0.000 claims 2
- 102100023123 Mucin-16 Human genes 0.000 claims 2
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 claims 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 2
- 102000003729 Neprilysin Human genes 0.000 claims 2
- 108090000028 Neprilysin Proteins 0.000 claims 2
- 102100040120 Prominin-1 Human genes 0.000 claims 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 2
- 229940100514 Syk tyrosine kinase inhibitor Drugs 0.000 claims 2
- 102100035721 Syndecan-1 Human genes 0.000 claims 2
- 102100037298 T cell receptor beta constant 2 Human genes 0.000 claims 2
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims 2
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims 2
- 101800000385 Transmembrane protein Proteins 0.000 claims 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims 2
- SRHNADOZAAWYLV-XLMUYGLTSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O SRHNADOZAAWYLV-XLMUYGLTSA-N 0.000 claims 2
- 229960003852 atezolizumab Drugs 0.000 claims 2
- 229950002916 avelumab Drugs 0.000 claims 2
- 210000001185 bone marrow Anatomy 0.000 claims 2
- 238000004113 cell culture Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000004186 co-expression Effects 0.000 claims 2
- 230000001086 cytosolic effect Effects 0.000 claims 2
- 229960002204 daratumumab Drugs 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 2
- 230000001605 fetal effect Effects 0.000 claims 2
- 229940014144 folate Drugs 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- 235000019152 folic acid Nutrition 0.000 claims 2
- 239000011724 folic acid Substances 0.000 claims 2
- 150000002270 gangliosides Chemical class 0.000 claims 2
- 239000000710 homodimer Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 102000006495 integrins Human genes 0.000 claims 2
- 108010044426 integrins Proteins 0.000 claims 2
- 108010074108 interleukin-21 Proteins 0.000 claims 2
- 230000003834 intracellular effect Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 2
- 229960003301 nivolumab Drugs 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 229960002621 pembrolizumab Drugs 0.000 claims 2
- 230000035515 penetration Effects 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 230000002829 reductive effect Effects 0.000 claims 2
- 108091006024 signal transducing proteins Proteins 0.000 claims 2
- 102000034285 signal transducing proteins Human genes 0.000 claims 2
- 108010082808 4-1BB Ligand Proteins 0.000 claims 1
- 102100022464 5'-nucleotidase Human genes 0.000 claims 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 1
- 101000840545 Bacillus thuringiensis L-isoleucine-4-hydroxylase Proteins 0.000 claims 1
- 108091032955 Bacterial small RNA Proteins 0.000 claims 1
- 102100025618 C-X-C chemokine receptor type 6 Human genes 0.000 claims 1
- 102100024263 CD160 antigen Human genes 0.000 claims 1
- 108010062802 CD66 antigens Proteins 0.000 claims 1
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims 1
- 229940045513 CTLA4 antagonist Drugs 0.000 claims 1
- 101100463133 Caenorhabditis elegans pdl-1 gene Proteins 0.000 claims 1
- 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 claims 1
- 102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 claims 1
- 101710093674 Cyclic nucleotide-gated cation channel beta-1 Proteins 0.000 claims 1
- 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 claims 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims 1
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 1
- 101000856683 Homo sapiens C-X-C chemokine receptor type 6 Proteins 0.000 claims 1
- 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims 1
- 101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 claims 1
- 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims 1
- 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 claims 1
- 101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 claims 1
- 101000840572 Homo sapiens Insulin-like growth factor-binding protein 4 Proteins 0.000 claims 1
- 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 claims 1
- 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 claims 1
- 101001049181 Homo sapiens Killer cell lectin-like receptor subfamily B member 1 Proteins 0.000 claims 1
- 101001139136 Homo sapiens Krueppel-like factor 3 Proteins 0.000 claims 1
- 101000605074 Homo sapiens Lipocalin-like 1 protein Proteins 0.000 claims 1
- 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 claims 1
- 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 claims 1
- 101001008429 Homo sapiens Nucleobindin-2 Proteins 0.000 claims 1
- 101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 claims 1
- 101001135402 Homo sapiens Prostaglandin-H2 D-isomerase Proteins 0.000 claims 1
- 101000905936 Homo sapiens RAS guanyl-releasing protein 2 Proteins 0.000 claims 1
- 101000708790 Homo sapiens SPARC-related modular calcium-binding protein 2 Proteins 0.000 claims 1
- 101000615384 Homo sapiens Stromal membrane-associated protein 2 Proteins 0.000 claims 1
- 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 claims 1
- 101000800047 Homo sapiens Testican-2 Proteins 0.000 claims 1
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims 1
- 101000979190 Homo sapiens Transcription factor MafB Proteins 0.000 claims 1
- 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 1
- 102100029571 Immunoglobulin J chain Human genes 0.000 claims 1
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 claims 1
- 102100029224 Insulin-like growth factor-binding protein 4 Human genes 0.000 claims 1
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 claims 1
- 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 claims 1
- 102000002698 KIR Receptors Human genes 0.000 claims 1
- 108010043610 KIR Receptors Proteins 0.000 claims 1
- 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 claims 1
- 102100020678 Krueppel-like factor 3 Human genes 0.000 claims 1
- 101150030213 Lag3 gene Proteins 0.000 claims 1
- 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims 1
- 102100038264 Lipocalin-like 1 protein Human genes 0.000 claims 1
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 claims 1
- 101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 claims 1
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims 1
- 102100021462 Natural killer cells antigen CD94 Human genes 0.000 claims 1
- 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 claims 1
- 102100027441 Nucleobindin-2 Human genes 0.000 claims 1
- 102100037589 OX-2 membrane glycoprotein Human genes 0.000 claims 1
- 102100035591 POU domain, class 2, transcription factor 2 Human genes 0.000 claims 1
- 101710084411 POU domain, class 2, transcription factor 2 Proteins 0.000 claims 1
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 1
- 102100033279 Prostaglandin-H2 D-isomerase Human genes 0.000 claims 1
- 102100023488 RAS guanyl-releasing protein 2 Human genes 0.000 claims 1
- 101150066717 Rara gene Proteins 0.000 claims 1
- 102100023606 Retinoic acid receptor alpha Human genes 0.000 claims 1
- 101001037255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Indoleamine 2,3-dioxygenase Proteins 0.000 claims 1
- 102100021250 Stromal membrane-associated protein 2 Human genes 0.000 claims 1
- 102100035268 T-cell surface protein tactile Human genes 0.000 claims 1
- 102100033371 Testican-2 Human genes 0.000 claims 1
- 102100024324 Toll-like receptor 3 Human genes 0.000 claims 1
- 102100023234 Transcription factor MafB Human genes 0.000 claims 1
- 102100025946 Transforming growth factor beta activator LRRC32 Human genes 0.000 claims 1
- 101710169732 Transforming growth factor beta activator LRRC32 Proteins 0.000 claims 1
- 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 claims 1
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims 1
- 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 229960000548 alemtuzumab Drugs 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229960002756 azacitidine Drugs 0.000 claims 1
- 229960000106 biosimilars Drugs 0.000 claims 1
- 210000000601 blood cell Anatomy 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 210000003850 cellular structure Anatomy 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 229960004497 dinutuximab Drugs 0.000 claims 1
- 230000003828 downregulation Effects 0.000 claims 1
- 229950009791 durvalumab Drugs 0.000 claims 1
- 229960004137 elotuzumab Drugs 0.000 claims 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims 1
- 239000012595 freezing medium Substances 0.000 claims 1
- 238000003881 globally optimized alternating phase rectangular pulse Methods 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 230000005746 immune checkpoint blockade Effects 0.000 claims 1
- 229940124622 immune-modulator drug Drugs 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 108040006861 interleukin-7 receptor activity proteins Proteins 0.000 claims 1
- 229960005386 ipilimumab Drugs 0.000 claims 1
- 229950007752 isatuximab Drugs 0.000 claims 1
- 230000002045 lasting effect Effects 0.000 claims 1
- 108010025001 leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims 1
- 239000003226 mitogen Substances 0.000 claims 1
- 229950001907 monalizumab Drugs 0.000 claims 1
- 229960003347 obinutuzumab Drugs 0.000 claims 1
- 229950009090 ocaratuzumab Drugs 0.000 claims 1
- 229960002450 ofatumumab Drugs 0.000 claims 1
- 229960002087 pertuzumab Drugs 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 229960000688 pomalidomide Drugs 0.000 claims 1
- UVSMNLNDYGZFPF-UHFFFAOYSA-N pomalidomide Chemical compound O=C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O UVSMNLNDYGZFPF-UHFFFAOYSA-N 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 108091008726 retinoic acid receptors α Proteins 0.000 claims 1
- 229960004641 rituximab Drugs 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229960000575 trastuzumab Drugs 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 229950004593 ublituximab Drugs 0.000 claims 1
- 230000003827 upregulation Effects 0.000 claims 1
- 229950000815 veltuzumab Drugs 0.000 claims 1
- 229960001183 venetoclax Drugs 0.000 claims 1
- LQBVNQSMGBZMKD-UHFFFAOYSA-N venetoclax Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 LQBVNQSMGBZMKD-UHFFFAOYSA-N 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962945040P | 2019-12-06 | 2019-12-06 | |
| US62/945,040 | 2019-12-06 | ||
| PCT/US2020/063457 WO2021113744A1 (fr) | 2019-12-06 | 2020-12-04 | Amélioration d'une cellule immunitaire effectrice dérivée d'ipsc à l'aide de petits composés |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505206A JP2023505206A (ja) | 2023-02-08 |
| JPWO2021113744A5 true JPWO2021113744A5 (fr) | 2023-12-11 |
Family
ID=76221001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533373A Pending JP2023505206A (ja) | 2019-12-06 | 2020-12-04 | 小化合物を使用するｉＰＳＣ由来エフェクター免疫細胞の増強 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230016034A1 (fr) |
| EP (1) | EP4069827A4 (fr) |
| JP (1) | JP2023505206A (fr) |
| KR (1) | KR20220124179A (fr) |
| CN (1) | CN115087731A (fr) |
| AU (1) | AU2020395239A1 (fr) |
| BR (1) | BR112022011072A2 (fr) |
| CA (1) | CA3160423A1 (fr) |
| IL (1) | IL293564A (fr) |
| MX (1) | MX2022006725A (fr) |
| WO (1) | WO2021113744A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR125851A1 (es) * | 2021-05-12 | 2023-08-16 | Crispr Therapeutics Ag | Células inmunes modificadas genéticamente que se focalizan en cd70 para su uso en el tratamiento de neoplasias malignas hematopoyéticas |
| US20230016422A1 (en) * | 2021-06-23 | 2023-01-19 | Crispr Therapeutics Ag | Engineered cells with improved protection from natural killer cell killing |
| JP2024526237A (ja) * | 2021-07-02 | 2024-07-17 | フェイト セラピューティクス，インコーポレイティド | 同種異系養子細胞療法のための保護されたエフェクター細胞及びその使用 |
| AU2022382407A1 (en) * | 2021-11-08 | 2024-05-23 | Fate Therapeutics, Inc. | Engineered effector cells and methods of enhancing ubiquitous targeting of solid tumors |
| WO2023143475A1 (fr) * | 2022-01-28 | 2023-08-03 | Hangzhou Qihan Biotechnology Co., Ltd. | Méthodes et compositions pour immunothérapies cellulaires |
| WO2023196994A1 (fr) * | 2022-04-08 | 2023-10-12 | Fate Therapeutics, Inc. | Cellules ayant un squelette de ciblage de tumeur solide et leur utilisation |
| WO2024097911A1 (fr) * | 2022-11-02 | 2024-05-10 | Fate Therapeutics, Inc. | Cellules thérapeutiques prêtes à l'emploi obtenues par ingénierie génomique multiplex pour le ciblage de gprc5d |
| CN117305241B (zh) * | 2023-11-28 | 2024-03-19 | 上海兴瑞一达生物科技有限公司 | 一种hiPSCs诱导分化为NK细胞的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3325504A1 (fr) * | 2015-07-21 | 2018-05-30 | Novartis AG | Méthodes pour améliorer l'efficacité et l'expansion de cellules immunitaires |
| EP3405568A4 (fr) * | 2016-01-20 | 2019-12-04 | Fate Therapeutics, Inc. | Compositions et procédés de modulation des cellules immunitaires en immunothérapies adoptives |
| JP6727334B2 (ja) * | 2016-02-01 | 2020-07-22 | グリーン・クロス・ラブ・セル・コーポレイション | 細胞の凍結保存のための培地組成物およびその使用 |
| PT3618842T (pt) * | 2017-05-01 | 2024-01-12 | Juno Therapeutics Inc | Combinação de uma terapia celular e de um composto imunomodulador |
| JP2020528885A (ja) * | 2017-07-19 | 2020-10-01 | フェイト セラピューティクス，インコーポレイテッド | 養子免疫療法における免疫細胞調節のための組成物および方法 |
| CN111556892A (zh) * | 2017-12-08 | 2020-08-18 | 菲特治疗公司 | 使用增强的iPSC衍生的效应细胞的免疫疗法 |
| MX2021000459A (es) * | 2018-07-13 | 2021-06-23 | Univ Kyoto | Metodo para producir celulas t gamma y delta. |
-
2020
- 2020-12-04 MX MX2022006725A patent/MX2022006725A/es unknown
- 2020-12-04 AU AU2020395239A patent/AU2020395239A1/en active Pending
- 2020-12-04 CA CA3160423A patent/CA3160423A1/fr active Pending
- 2020-12-04 EP EP20896968.3A patent/EP4069827A4/fr active Pending
- 2020-12-04 JP JP2022533373A patent/JP2023505206A/ja active Pending
- 2020-12-04 IL IL293564A patent/IL293564A/en unknown
- 2020-12-04 BR BR112022011072A patent/BR112022011072A2/pt unknown
- 2020-12-04 WO PCT/US2020/063457 patent/WO2021113744A1/fr unknown
- 2020-12-04 KR KR1020227023102A patent/KR20220124179A/ko unknown
- 2020-12-04 US US17/782,600 patent/US20230016034A1/en active Pending
- 2020-12-04 CN CN202080095636.2A patent/CN115087731A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yilmaz et al. | Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy | |
| JP2021505131A5 (fr) | ||
| JP6678215B2 (ja) | がんにおけるｃｄ１３８の標的化 | |
| KR102618231B1 (ko) | 변형된 만능성 줄기 세포, 및 제조 및 사용 방법 | |
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| Maher | Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells | |
| JP7005346B2 (ja) | 養子細胞免疫療法の有効性を増強させるための組成物および方法 | |
| JP6961497B2 (ja) | キメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 | |
| Bollino et al. | Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy | |
| JP7505885B2 (ja) | 腫瘍微小環境を標的にするキメラ抗原受容体ｔ細胞 | |
| KR102600544B1 (ko) | 트랜스진 유전자 태그 및 사용 방법 | |
| JP2021040652A (ja) | Ｇタンパク質共役受容体を標的化するキメラ抗原受容体およびその使用 | |
| EP2964675B1 (fr) | Cellules d'engagement pour immunothérapie | |
| JP2021121222A (ja) | 二重特異性キメラ抗原受容体およびその治療的使用 | |
| CA3107675A1 (fr) | Amelioration de l'efficacite et de la securite de therapies cellulaires adoptives | |
| JPWO2021011919A5 (fr) | ||
| KR20230129983A (ko) | 조작된 세포 요법을 위한 표적화된 사이토카인 구축물 | |
| Wang et al. | New approaches in CAR-T cell immunotherapy for breast cancer | |
| Zuo et al. | Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers | |
| JP2024502157A (ja) | 樹状細胞活性化キメラ抗原受容体及びその使用 | |
| JP2023029624A (ja) | ｓｔｒｅｐタグ特異的キメラ受容体およびその使用 | |
| Lichtman et al. | Chimeric antigen receptor T-cells for B-cell malignancies | |
| KR20180021683A (ko) | 생체내 지속성 및 치료학적 활성 및 이의 증식을 위한 nkt-세포 서브세트 | |
| EP3805366A1 (fr) | Méthode de thérapie par lymphocytes t améliorée | |
| JPWO2021062281A5 (fr) |